# A Clinical Trial to Compare The Pharmacokinetics of A Pregabalin GLARS Tablet 150mg With Immediate Release Formulation and to Assess The Effect of High Fat Diet in Healthy Male Subjects

> **NCT01635751** · PHASE1 · COMPLETED · sponsor: **GL Pharm Tech Corporation** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Pregabalin
- **DRUG:** Pregabalin
- **DRUG:** Pregabalin

## Key facts

- **NCT ID:** NCT01635751
- **Lead sponsor:** GL Pharm Tech Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01635751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01635751, "A Clinical Trial to Compare The Pharmacokinetics of A Pregabalin GLARS Tablet 150mg With Immediate Release Formulation and to Assess The Effect of High Fat Diet in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01635751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*